| Ytd | -98.87% | |
| 1y | -99.53% |
| Open | 0.87 | Prev Close | 0.89 | Low | 0.87 | High | 0.89 | Mkt Cap | 297.19K |
| Vol | 13.86K | Avg Vol | 1.05M | EPS | -45.63 | P/E | -0.02 | Forward P/E | -0.41 |
| Beta | 2.69 | Short Ratio | 0.45 | Inst. Own | 7.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-31 | 50-d Avg | 1.42 | 200-d Avg | 60.66 | 1yr Est | 9.00 |
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m
STOCKHOLM — June 17, 2026 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company speci
US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports
Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company"), a commercial-stage bio
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial
Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initi
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent incr
Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the compan
Onconetix shares are surging Thursday afternoon after the company highlighted a product milestone fr
Dow up 0.77% to 48,278.43, NASDAQ up 0.83% to 22,822.04, S&P 500 up 0.69% to 6,829.76. Utilities
Stocks fall on weak economic growth and tech stocks decline in morning trading. Utilities up 1.6%, I
Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") is providing the follo
Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") today announced the ap
Onconetix (ONCO) shares surge 71% premarket following the Realbotix acquisition update and 1-for-5 r
U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 reven
Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-mar
Onconetix, Inc. (NASDAQ: ONCO) ("Onconetix" or the "Company"), a commercial-stage bi